We serve Boc-4-Methoxyphenylalanine CAS:53267-93-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name: Boc-4-Methoxyphenylalanine
CAS.NO: 53267-93-9
Molecular Formula: C15H21NO5
Molecular Weight:295.33100
Synonyms:
(2S)-2-[(tert-Butoxycarbonyl)amino]-3-(4-methoxyphenyl)propanoic acid
(2S)-3-(4-methoxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid
Physical and Chemical Properties:
Density: 1.168g / cm3
Boiling point: 462ºC at 760 mmHg
Flash point: 233.2ºC
Refractive index: 1.522
Specification:
Appearance: White powder
Purity:≥98%
Moisture Content: <0.5%
Impurity: <0.5%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Storage at 0-5ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:Pharmaceutical intermediates.
Contact us for information like Boc-4-Methoxyphenylalanine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(2S)-3-(4-methoxyphenyl)-2-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Boc-4-Methoxyphenylalanine Use and application,(2S)-2-[(tert-Butoxycarbonyl)amino]-3-(4-methoxyphenyl)propanoic acid technical grade,usp/ep/jp grade.
Related News: New Zealand citizens and permanent residents and their immediate family members will still be able to enter — but must self-isolate for 14 days after arriving back into the country.2',3'-Dideoxyguanosine manufacturer The current outbreak has been dubbed “Wuhan virus”, named after the city where the first report emerged in January.4-Chlorophenylacetonitrile supplier Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.2,3-dihydrobenzofuran vendor Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.Established pharmaceutical companies have abandoned the original model of the entire industry chain, stripped R & D and production links through outsourcing, and shifted their focus to product layout and global operations.
